Zenas BioPharma, Inc. (ZBIO)
21.74
+0.69
(+3.28%)
USD |
NASDAQ |
Apr 16, 16:00
21.74
0.00 (0.00%)
After-Hours: 19:35
Zenas BioPharma Shareholders Equity (Quarterly) : 242.14M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 477.32M |
| AnaptysBio, Inc. | 37.21M |
| Gilead Sciences, Inc. | 22.70B |
| Nkarta, Inc. | 312.32M |
| Cullinan Therapeutics, Inc. | 408.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.64M |
| Total Liabilities (Quarterly) | 141.50M |
| Debt to Equity Ratio | 0.3302 |
| Current Ratio | 5.605 |
| Net Debt Paydown Yield | -0.80% |